Even before SARS-Cov-2, the cost of health care has skyrocketed over the last 20 years and the industry is in dire need of radical change.
Advanced medical devices, breakthroughs in new biologic drugs and other amazing technologies also offer a tremendous promise of amazing things to come.
Digital technology is also finally finding its way into the sector and artificial intelligence offers enormous possibilities across the value chain of the space running from drug development to diagnosis and dosage control.
The advantage of the space is that it is critically important for humanity and the world. The challenge is that things are changing quickly and it may be difficult to know which aspect of the space to get involved with.